The Vatican has entered a joint initiative with international bio-pharmaceutical company Neostem to research adult stem cell therapy and explore the use of the cells in regenerative medicine. Neostem and the Pontifical Council for Culture will combine the efforts of their respective foundations, the Stem for Life Foundation and STOQ (Science Theology and the Ontological Quest) Foundation, according to a Catholic News Agency report.
Father Tomasz Trafny, from the Council for Culture, remarked in a press release last week: "Considering the potential implication of scientific investigation, medical applicability and the cultural impact of research on adult stem cells, we view the collaboration with NeoStem as a critical effort.
"Through educational initiatives with NeoStem and sponsorship of scientific research programs involving cutting edge adult stem cell science which does not hurt human life, we come one step closer to a breakthrough that can relieve needless human suffering," he said.
The pontifical council is particularly excited about the company's VSEL technology, which utilises adult stem cells that behave like embryonic stem cells in their ability to regenerate and repair. Fr Trafny said the technology could receive a significant financial investment from the Church.
The initiative will also explore the cultural relevance and theological impact of adult stem cell therapy.
SIC: CTHAUS